Matthew P. Deek
About
Matthew P. Deek is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Oncology.
According to data from OpenAlex, Matthew P. Deek has authored 69 papers receiving a total of 512 indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Pulmonary and Respiratory Medicine, 32 papers in Radiology, Nuclear Medicine and Imaging and 15 papers in Oncology. Recurrent topics in Matthew P. Deek's work include Prostate Cancer Treatment and Research (30 papers), Prostate Cancer Diagnosis and Treatment (22 papers) and Radiopharmaceutical Chemistry and Applications (16 papers). Matthew P. Deek is often cited by papers focused on Prostate Cancer Treatment and Research (30 papers), Prostate Cancer Diagnosis and Treatment (22 papers) and Radiopharmaceutical Chemistry and Applications (16 papers). Matthew P. Deek collaborates with scholars based in United States, Türkiye and Belgium. Matthew P. Deek's co-authors include Salma K. Jabbour, Phuoc T. Tran, Sinae Kim, Joseph Aisner, Ryan Phillips, Jyoti Malhotra, Nikhil Yegya‐Raman, Theodore L. DeWeese, Meral Reyhan and Mutlay Sayan and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and European Urology.
In The Last Decade
Matthew P. Deek
62 papers receiving 505 citations
Peers
Matthew P. Deek
Terence T. Sio United States
Edward F. Miles United States
Tanja Baresic Italy
Gaia Piperno Italy
Tommy Sheu United States
Prashant Gabani United States
Ezra Hahn Canada
Dieter Berwouts Belgium
Nathan R. Bennion United States
Eleni Gkika Germany
Citations per year, relative to Matthew P. Deek Matthew P. Deek (= 1×)
peers
Terence T. Sio
Countries citing papers authored by Matthew P. Deek
Since
Specialization
Citations
This map shows the geographic impact of Matthew P. Deek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew P. Deek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew P. Deek more than expected).
Fields of papers citing papers by Matthew P. Deek
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Matthew P. Deek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew P. Deek. The network helps show where Matthew P. Deek may publish in the future.
Co-authorship network of co-authors of Matthew P. Deek
This figure shows the co-authorship network connecting the top 25 collaborators of Matthew P. Deek. A scholar is included among the top collaborators of Matthew P. Deek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew P. Deek. Matthew P. Deek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Sherry, Alexander D., Cara Haymaker, Bryan Fellman, et al.. (2025). Metastasis-directed therapy (MDT) plus androgen deprivation therapy (ADT) for oligometastatic prostate cancer (omPC): Primary results of the EXTEND continuous ADT (cADT) basket plus combined analysis with the updated intermittent ADT (iADT) basket and immune correlatives.. Journal of Clinical Oncology. 43(5_suppl). 140–140.
2.
Shi, Xiaolei, Jarey H. Wang, Brian F. Chapin, et al.. (2025). Integrating systemic therapy and metastasis-directed therapy in oligometastatic hormone-sensitive prostate cancer. Prostate Cancer and Prostatic Diseases.
3.
Sutera, Philip, Jongmyung Kim, Ritesh Kumar, et al.. (2024). PIK3/Akt/mTOR pathway alterations in metastatic castration‐sensitive prostate cancer. The Prostate. 84(14). 1301–1308.
4.
Malhotra, Jyoti, Mona Arbab, Matthew P. Deek, et al.. (2024). Two phase 2A clinical trials to evaluate the safety and efficacy of IMSA101 in combination with radiotherapy and checkpoint inhibitors in oligometastatic and oligoprogressive solid tumor malignancies.. Journal of Clinical Oncology. 42(16_suppl). TPS2685–TPS2685.
5.
Deek, Matthew P., et al.. (2024). Local Excision for Early-Stage Rectal Adenocarcinomas. The Cancer Journal. 30(4). 245–250.
6.
Sutera, Philip, Matthew P. Deek, Adrianna A. Mendes, et al.. (2024). Validation of a Digital Pathology-Based Multimodal Artificial Intelligence Model in Oligometastatic Castration-Sensitive Prostate Cancer, including in Patients from the STOMP and ORIOLE Phase II Randomized Clinical Trials. International Journal of Radiation Oncology*Biology*Physics. 120(2). S133–S133.
7.
Wang, Jue, et al.. (2024). Outcomes of RAdium-223 and SABR vs. SABR for oligomEtastatic prostate caNcerS – The RAVENS Phase II Randomized Trial. International Journal of Radiation Oncology*Biology*Physics. 120(2). S7–S7.
8.
Sutera, Philip, Matthew P. Deek, Ryan Phillips, et al.. (2024). Machine learning predicts conventional imaging metastasis-free survival (MFS) for oligometastatic castration-sensitive prostate cancer (omCSPC) using prostate-specific membrane antigen (PSMA) PET radiomics. Radiotherapy and Oncology. 199. 110443–110443.
9.
Sutera, Philip, Amol C. Shetty, Yang Song, et al.. (2023). Identification of a Predictive Genomic Biomarker for Prostate-directed Therapy in Synchronous Low-volume Metastatic Castration-sensitive Prostate Cancer. European Urology Oncology. 7(2). 241–247.
10.
Deek, Matthew P., Noura Radwan, Catherine H. Marshall, et al.. (2023). Prospective Characterization of Circulating Tumor Cells in Hormone Sensitive Oligometastatic Prostate Cancer Patients on a Metastasis-Directed Therapy Trial. International Journal of Radiation Oncology*Biology*Physics. 117(2). e367–e368.
11.
Sutera, Philip, Amol C. Shetty, Yang Song, et al.. (2023). Identification of a Predictive Genomic Biomarker for Prostate Directed Therapy in Synchronous Low-Volume Metastatic Castration Sensitive Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 117(2). e441–e442.
12.
Pfail, John, Biren Saraiya, Tina Mayer, et al.. (2023). Metastasis-Directed Therapy for Oligometastatic Castration-Sensitive Prostate Cancer: An Alternative to ADT?. Current Urology Reports. 24(7). 299–306.
13.
Rana, Zaker, Jason K. Molitoris, Matthew J. Ferris, et al.. (2023). Phase 2 randomized total eradication of metastatic lesions following definitive radiation to the prostate in de novo oligometastatic prostate cancer (TERPs) trial.. Journal of Clinical Oncology. 41(6_suppl). TPS275–TPS275.
14.
Yegya‐Raman, Nikhil, et al.. (2023). Stereotactic Body Radiation Therapy in Gynecologic Oligometastases: An Effective but Underutilized Approach. Cancers. 15(13). 3526–3526.
15.
Deek, Matthew P., Sue S. Yom, Hasan Rehman, et al.. (2021). Can Sex and Seniority Predict the Quality of a Journal Reviewer's Manuscript Critique?. International Journal of Radiation Oncology*Biology*Physics. 111(2). 312–316.
16.
Deek, Matthew P., Kekoa Taparra, Ryan Phillips, et al.. (2020). Metastasis-directed Therapy Prolongs Efficacy of Systemic Therapy and Improves Clinical Outcomes in Oligoprogressive Castration-resistant Prostate Cancer. European Urology Oncology. 4(3). 447–455.
17.
Deek, Matthew P., Peijin Han, Carole Fakhry, et al.. (2019). Long Term Toxicity and Oncologic Outcomes of De-Intensified Chemoradiation in Early Stage Oropharyngeal Carcinoma. International Journal of Radiation Oncology*Biology*Physics. 105(1). S215–S216.
18.
Deek, Matthew P., Sinae Kim, Mutlay Sayan, et al.. (2019). Vertebral body irradiation during chemoradiation therapy for esophageal cancer contributes to acute bone marrow toxicity. Journal of Gastrointestinal Oncology. 10(3). 513–522.
19.
Deek, Matthew P., Ryan Phillips, Daniel Y. Song, et al.. (2019). Radiation Therapy in the Definitive Management of Oligometastatic Prostate Cancer: The Johns Hopkins Experience. International Journal of Radiation Oncology*Biology*Physics. 105(5). 948–956.
20.
Yegya‐Raman, Nikhil, Kyle Wang, Sinae Kim, et al.. (2018). Dosimetric Predictors of Symptomatic Cardiac Events After Conventional-Dose Chemoradiation Therapy for Inoperable NSCLC. Journal of Thoracic Oncology. 13(10). 1508–1518.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Terence T. Sio Breakdown of academic impact, for papers by Edward F. Miles Breakdown of academic impact, for papers by Tanja Baresic Breakdown of academic impact, for papers by Gaia Piperno Breakdown of academic impact, for papers by Tommy Sheu Breakdown of academic impact, for papers by Prashant Gabani Breakdown of academic impact, for papers by Ezra Hahn Breakdown of academic impact, for papers by Dieter Berwouts Breakdown of academic impact, for papers by Nathan R. Bennion Breakdown of academic impact, for papers by Eleni Gkika